Insider · CIK 0001838503
Christopher I Wright
Files at ALKS (Alkermes plc.). First filing Jun 12, 2026, latest Jun 12, 2026.
In brief
Christopher I Wright files SEC Form 4 as director at ALKS (Alkermes plc.). Since Jun 12, 2026, Christopher I Wright has reported 0 open-market buys worth $0 and 1 open-market sell worth $90k, the latest filed on Jun 12, 2026.
A track record needs three past buys with six months of prices behind them; Christopher I Wright has 0, so none is measured yet.
The newest scored trade: sold $90k of ALKS on Jun 12, 2026, filed Jun 12, 2026, scored 19 (weak), under a 10b5-1 plan. In the last 12 months: 0 buys worth $0 and 1 sell worth $90k.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
ALKS: Alkermes plc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 19Weak | Alkermes plc. | $90k 2,000 shares | -7% | +69% from low-1% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Jun 12, 2026 | ALKS Alkermes plc. | 2,000 0.00% of outstanding | $90k | Jun 12, 2026 | none |
Transactions
Every row this insider has filed, 28 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 12, 2026 | ALKS Alkermes plc. | SOpen-market sale Ordinary Shares10b5-1 | -2,000 | $45.10 | $90k | 25,680 | Jun 12, 2026 |
| May 21, 2026 | ALKS Alkermes plc. | MOption exercise Ordinary Shares | +6,142 | - | - | 29,155 | May 22, 2026 |
| May 21, 2026 | ALKS Alkermes plc. | FTax withholding Ordinary Shares | -1,475 | $36.95 | $55k | 27,680 | May 22, 2026 |
| May 20, 2026 | ALKS Alkermes plc. | AGrant or award Non Qualified Stock Option (Right to Buy)derivative | +11,538 | $0.00 | $0 | 11,538 | May 22, 2026 |
| May 20, 2026 | ALKS Alkermes plc. | AGrant or award Restricted Stock Unit Awardderivative | +5,409 | $0.00 | $0 | 5,409 | May 22, 2026 |
| May 21, 2026 | ALKS Alkermes plc. | MOption exercise Restricted Stock Unit Awardderivative | -6,142 | - | - | 0 | May 22, 2026 |
| Jun 8, 2025 | ALKS Alkermes plc. | MOption exercise Ordinary Shares | +3,301 | - | - | 23,806 | Jun 10, 2025 |
| Jun 8, 2025 | ALKS Alkermes plc. | FTax withholding Ordinary Shares | -793 | $31.71 | $25k | 23,013 | Jun 10, 2025 |
| Jun 8, 2025 | ALKS Alkermes plc. | MOption exercise Restricted Stock Unit Awardderivative | -3,301 | - | - | 0 | Jun 10, 2025 |
| May 31, 2025 | ALKS Alkermes plc. | MOption exercise Ordinary Shares | +8,013 | - | - | 22,429 | Jun 2, 2025 |
| May 31, 2025 | ALKS Alkermes plc. | FTax withholding Ordinary Shares | -1,924 | $30.61 | $59k | 20,505 | Jun 2, 2025 |
| May 31, 2025 | ALKS Alkermes plc. | MOption exercise Restricted Stock Unit Awardderivative | -8,013 | - | - | 0 | Jun 2, 2025 |
| May 21, 2025 | ALKS Alkermes plc. | AGrant or award Non Qualified Stock Option (Right to Buy)derivative | +13,474 | $0.00 | $0 | 13,474 | May 23, 2025 |
| May 21, 2025 | ALKS Alkermes plc. | AGrant or award Restricted Stock Unit Awardderivative | +6,142 | $0.00 | $0 | 6,142 | May 23, 2025 |
| Jun 29, 2024 | ALKS Alkermes plc. | MOption exercise Ordinary Shares | +6,104 | - | - | 15,881 | Jul 1, 2024 |
| Jun 29, 2024 | ALKS Alkermes plc. | FTax withholding Ordinary Shares | -1,465 | $24.10 | $35k | 14,416 | Jul 1, 2024 |
| Jun 29, 2024 | ALKS Alkermes plc. | MOption exercise Restricted Stock Unit Awardderivative | -6,104 | - | - | 0 | Jul 1, 2024 |
| Jun 8, 2024 | ALKS Alkermes plc. | MOption exercise Ordinary Shares | +3,301 | - | - | 10,570 | Jun 10, 2024 |
| Jun 8, 2024 | ALKS Alkermes plc. | FTax withholding Ordinary Shares | -793 | $23.91 | $19k | 9,777 | Jun 10, 2024 |
| Jun 8, 2024 | ALKS Alkermes plc. | MOption exercise Restricted Stock Unit Awardderivative | -3,301 | - | - | 3,301 | Jun 10, 2024 |
| Nov 17, 2023 | ALKS Alkermes plc. | JOther Non Qualified Stock Option (Right to Buy)derivative | +14 | $28.40 | $398 | 728 | Jun 4, 2024 |
| Nov 17, 2023 | ALKS Alkermes plc. | JOther Non Qualified Stock Option (Right to Buy)derivative | +355 | $28.40 | $10k | 18,128 | Jun 4, 2024 |
| Nov 17, 2023 | ALKS Alkermes plc. | JOther Restricted Stock Unit Awardderivative | +129 | - | - | 6,602 | Jun 4, 2024 |
| Nov 17, 2023 | ALKS Alkermes plc. | JOther Non Qualified Stock Option (Right to Buy)derivative | +231 | $30.86 | $7,129 | 11,785 | Jun 4, 2024 |
| Nov 17, 2023 | ALKS Alkermes plc. | JOther Non Qualified Stock Option (Right to Buy)derivative | +254 | $30.72 | $7,803 | 12,986 | Jun 4, 2024 |
| Nov 17, 2023 | ALKS Alkermes plc. | JOther Restricted Stock Unit Awardderivative | +119 | - | - | 6,104 | Jun 4, 2024 |
| May 31, 2024 | ALKS Alkermes plc. | AGrant or award Restricted Stock Unit Awardderivative | +8,013 | $0.00 | $0 | 8,013 | Jun 4, 2024 |
| May 31, 2024 | ALKS Alkermes plc. | AGrant or award Non Qualified Stock Option (Right to Buy)derivative | +17,492 | $0.00 | $0 | 17,492 | Jun 4, 2024 |
Questions about Christopher I Wright
Answered from the filings on this page, as of the latest one.
Is Christopher I Wright buying or selling?
In the last 12 months Christopher I Wright reported 0 open-market buys worth $0 and 1 open-market sell worth $90k on SEC Form 4; the latest was sold $90k of ALKS on Jun 12, 2026. Grants, option exercises and tax withholding are not counted.
How did Christopher I Wright's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Christopher I Wright has 0.
Where does Christopher I Wright file Form 4?
Christopher I Wright has filed Form 4 at ALKS (Alkermes plc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.